Cargando…

Remifentanil vs conventional sedation in The Netherlands: a pharmacoeconomic model analysis

Detalles Bibliográficos
Autores principales: Al, M, Hakkaart, L, Tan, S, Mulder, P, Bakker, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095480/
http://dx.doi.org/10.1186/cc5587
_version_ 1782326035623182336
author Al, M
Hakkaart, L
Tan, S
Mulder, P
Bakker, J
author_facet Al, M
Hakkaart, L
Tan, S
Mulder, P
Bakker, J
author_sort Al, M
collection PubMed
description
format Online
Article
Text
id pubmed-4095480
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40954802014-07-14 Remifentanil vs conventional sedation in The Netherlands: a pharmacoeconomic model analysis Al, M Hakkaart, L Tan, S Mulder, P Bakker, J Crit Care Poster Presentation BioMed Central 2007 2007-03-22 /pmc/articles/PMC4095480/ http://dx.doi.org/10.1186/cc5587 Text en Copyright © 2007 BioMed Central Ltd.
spellingShingle Poster Presentation
Al, M
Hakkaart, L
Tan, S
Mulder, P
Bakker, J
Remifentanil vs conventional sedation in The Netherlands: a pharmacoeconomic model analysis
title Remifentanil vs conventional sedation in The Netherlands: a pharmacoeconomic model analysis
title_full Remifentanil vs conventional sedation in The Netherlands: a pharmacoeconomic model analysis
title_fullStr Remifentanil vs conventional sedation in The Netherlands: a pharmacoeconomic model analysis
title_full_unstemmed Remifentanil vs conventional sedation in The Netherlands: a pharmacoeconomic model analysis
title_short Remifentanil vs conventional sedation in The Netherlands: a pharmacoeconomic model analysis
title_sort remifentanil vs conventional sedation in the netherlands: a pharmacoeconomic model analysis
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095480/
http://dx.doi.org/10.1186/cc5587
work_keys_str_mv AT alm remifentanilvsconventionalsedationinthenetherlandsapharmacoeconomicmodelanalysis
AT hakkaartl remifentanilvsconventionalsedationinthenetherlandsapharmacoeconomicmodelanalysis
AT tans remifentanilvsconventionalsedationinthenetherlandsapharmacoeconomicmodelanalysis
AT mulderp remifentanilvsconventionalsedationinthenetherlandsapharmacoeconomicmodelanalysis
AT bakkerj remifentanilvsconventionalsedationinthenetherlandsapharmacoeconomicmodelanalysis